Safety assessment of a novel water-soluble extract of Boswellia serrata gum resin: acute toxicity, 90-day sub-chronic toxicity, Ames’ bacterial reverse mutation, and in vivo micronucleus assays

References

• Abdel-Tawab M, Werz O, Schubert-Zsilavecz M. 2011. Boswellia serrata: an overall assessment of in vitro, preclinical, pharmacokinetic and clinical data. Clin Pharmacokinet. 50(6):349–369.
   PubMed Web of Science ®Google Scholar
• Alluri VK, Dodda S, Kilari EK, Golakoti T, Sengupta K. 2019. Toxicological assessment of a standardized Boswellia serrata gum resin extract. Int J Toxicol. 38(5):423–435.
   PubMed Web of Science ®Google Scholar
• Ames BN, McCann J, Yamasaki E. 1977. Methods for the Salmonella mutagenicity test. In: Kilbey BJ, editor. Handbook of mutagenicity test procedures. Amsterdam: Elsevier; p. 1–17.
   Google Scholar
• Ammon HP. 2006. Boswellic acids in chronic inflammatory diseases. Planta Med. 72(12):1100–1116.
   PubMed Web of Science ®Google Scholar
• Aydιn A, Aktay G, Yesilada E. 2016. A guidance manual for the toxicity assessment of traditional herbal medicines. Nat Prod Commun. 11(11):1763–1773.
   PubMed Web of Science ®Google Scholar
• Chatterjee GK, Pal SD. 1984. Anti-inflammatory agents from Indian medicinal plants. Indian Drugs. 21:431.
   Google Scholar
• [CFR] Code of Federal Regulations Title 21. 2007. March US Food and Drug Administration. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/cfrsearch.cfm?fr¼172.510.
   Google Scholar
• Davis B, Sengupta K, Alluri VK, Golakoti T. 2019. Plasma concentrations of boswellic acids in fasting healthy humans supplemented with a water-soluble Boswellia extract (78% AKBA) vs. reference boswellia extract (30% AKBA). Curr Dev Nutr. 3(Supp. l):P06-005-19.
   Google Scholar
• Dhiman AK. 2006. Ayurvedic drug plants. Delhi: Daya Publishing House.
   Google Scholar
• Draize JH, Woodward G, Calvary HO. 1944. Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes. J Pharmacol Exp Ther. 82(3):377–390.
   Google Scholar
• Etzel R. 1996. Special extract of Boswellia serrata (H 15) in the treatment of rheumatoid arthritis. Phytomedicine. 3(1):91–94.
   PubMed Web of Science ®Google Scholar
• Gerbeth K, Hüsch J, Fricker G, Werz O, Schubert-Zsilavecz M, Abdel-Tawab M. 2013. In vitro metabolism, permeation, and brain availability of six major boswellic acids from Boswellia serrata gum resins. Fitoterapia. 84:99–106.
   PubMed Web of Science ®Google Scholar
• Giknis MLA, Clifford CB. 2006. Clinical laboratory parameters for Crl:CD(SD) rats. Wilmington (MA): Charles River Laboratories.
   Google Scholar
• Hamidpour R, Hamidpour S, Hamidpour M, Shahlari M. 2013. Frankincense (Rǔ Xiāng; Boswellia species): from the selection of traditional applications to the novel phytotherapy for the prevention and treatment of serious diseases. J Tradit Complement Med. 3(4):221–226.
   PubMedGoogle Scholar
• Kay JH, Calandra JC. 1962. Interpretation of eye irritation tests. J Soc Cos Chem. 13:281–289.
   Google Scholar
• OECD Series on Testing and Assessment, No. 33. 2001. Harmonized integrated classification system for human health and environmental hazards of chemical substances and mixtures. Paris: OECD Publishing.
   Google Scholar
• OECD Test No. 402. 1987. Acute dermal toxicity (adopted February 24 1987). Paris: OECD Publishing. https://doi.org/http://dx.doi.org/10.1787/9789264070585-en
   Google Scholar
• OECD Test No. 404. 2002. Acute dermal irritation/corrosion. Paris: OECD Publishing. https://doi.org/https://doi.org/10.1787/9789264070622-en
   Google Scholar
• OECD Test No. 405. 2002. Acute eye irritation/corrosion. Paris: OECD Publishing.
   Google Scholar
• OECD Test No. 425. 2008. Acute oral toxicity: up-and-down procedure, OECD guidelines for the testing of chemicals, section 4. Paris: OECD Publishing.
   Google Scholar
• OECD Test No. 474. 2014. Mammalian erythrocyte micronucleus test. Paris: OECD Publishing.
   Google Scholar
• OECD Test No. 408. 2018. Repeated dose 90-day oral toxicity study in rodents, OECD guidelines for the testing of chemicals, section 4. Paris: OECD Publishing.
   Google Scholar
• Roy NK, Dey P, Banik K, Bordoloi D, Devi AK, Thakur KK, Ganesan P, Mehdi S, Lu F, Sethi G, et al. 2019. An update on pharmacological potential of boswellic acids against chronic diseases. IJMS. 20(17):4101.
   Google Scholar
• Roy S, Khanna S, Shah H, Rink C, Phillips C, Preuss H, Subbaraju GV, Golakoti T, Alluri VK, Bagchi M, et al. 2005. Human genome screen to identify the genetic basis of the anti-inflammatory effects of Boswellia in microvascular endothelial cells. DNA Cell Biol. 24(4):244–255.
   PubMed Web of Science ®Google Scholar
• Safayhi H, Mack T, Sabieraj J, Anazodo MI, Subramanian LR, Ammon HP. 1992. Boswellic acids: novel, specific, nonredox inhibitors of 5-lipoxygenase. J Pharmacol Exp Ther. 261(3):1143–1146.
   PubMed Web of Science ®Google Scholar
• Sengupta K, Alluri KV, Satish AR, Mishra S, Golakoti T, Sarma KV, Dey D, Raychaudhuri SP. 2008. A double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin for treatment of osteoarthritis of the knee. Arthritis Res Ther. 10(4):R85.
   PubMed Web of Science ®Google Scholar
• Sengupta K, Golakoti T, Marasetti AK, Tummala T, Ravada SR, Alluri KV, Raychaudhuri SP. 2009. Inhibition of TNFα production and blocking of mitogen-activated protein kinase/NFκB activation in lipopolysaccharide-induced THP-1 human monocytes by 3-o-acetyl-11-keto-β-boswellic acid. J Food Lipids. 16(3):325–344.
   Google Scholar
• Sengupta K, Kolla JN, Krishnaraju AV, Yalamanchili N, Rao CV, Golakoti T, Raychaudhuri S, Raychaudhuri SP. 2011. Cellular and molecular mechanisms of anti-inflammatory effect of Aflapin: a novel Boswellia serrata extract. Mol Cell Biochem. 354(1–2):189–197..
   PubMed Web of Science ®Google Scholar
• Sengupta K, Krishnaraju AV, Vishal AA, Mishra A, Trimurtulu G, Sarma KV, Raychaudhuri SK, Raychaudhuri SP. 2010. Comparative efficacy and tolerability of 5-Loxin and AflapinAgainst osteoarthritis of the knee: a double blind, randomized, placebo controlled clinical study. Int J Med Sci. 7(6):366–377.
   PubMed Web of Science ®Google Scholar
• Shah SU. 2012. Importance of genotoxicity & S2A guidelines for genotoxicity testing for pharmaceuticals. IOSJPBS. 1(2):43–54.
   Google Scholar
• Singh P, Chacko KM, Aggarwal ML, Bhat B, Khandal RK, Sultana S, Kuruvilla BT. 2012. A-90 day gavage safety assessment of Boswellia serrata in rats. Toxicol Int. 19(3):273–278.
   PubMedGoogle Scholar
• Syrovets T, Büchele B, Krauss C, Laumonnier Y, Simmet T. 2005. Acetyl-boswellic acids inhibit lipopolysaccharide-mediated TNF-alpha induction in monocytes by direct interaction with IkappaB kinases. J Immunol. 174(1):498–506.
   PubMed Web of Science ®Google Scholar
• Teo S, Stirling D, Thomas S, Hoberman A, Kiorpes A, Khetani V. 2002. A 90 days oral gavage toxicity study of d-methylphenidate and d, l-methylphenidate in Sprague-Dawley rats. Toxicology. 179(3):183–196.
   PubMed Web of Science ®Google Scholar
• Vishal AA, Mishra A, Raychaudhuri SP. 2011. A double blind, randomized, placebo controlled clinical study evaluates the early efficacy of aflapin in subjects with osteoarthritis of knee. Int J Med Sci. 8(7):615–622.
   PubMed Web of Science ®Google Scholar
• Yu G, Xiang W, Zhang T, Zeng L, Yang K, Li J. 2020. Effectiveness of Boswellia and Boswellia extract for osteoarthritis patients: a systematic review and meta-analysis. BMC Complement Med Ther. 20(1):225.
   PubMedGoogle Scholar